- Filed
- May 9, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $2.74B |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $2.49B |
| Total Assets | Q1 2024 · Mar 31, 2024 | $3.96B |
| Total Assets | Q1 2024 · Dec 31, 2023 | $3.68B |
| Dividends Paid | Q1 2024 · Dec 31, 2023 | $30.5M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $120.26M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2023 | $147.78M |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 60.9M sh |
| Stock Repurchased | Q1 2024 · Mar 31, 2023 | $568K |
| Capex restated | Q1 2024 · Mar 31, 2023 | $1.07M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$29.55M |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.61 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.61 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $20.88M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$37.19M |